Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: Drug Dev Res. 1996 Sep 1;39(1):36–46. doi: 10.1002/(sici)1098-2299(19960901)39:1<36::aid-ddr5>3.0.co;2-l

Figure 7.

Figure 7

Effect of NECA and 2-CI-IBMECA on the presence of DNP-HSA on intracellular calcium levels in RBL-2H3 mast cells. Cells were prelabeled with fura-2 as described in Methods. Additions (arrows) were as follows: A: DNP-HSA, 20 ng/ml; B: NECA (1 µM) plus DNP-HSA; C: 2-CI-IBMECA (1 µM) plus DNP-HSA.